echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > The UK became the first country in the world to start getting the new Oxford-AstraZeneta vaccine

    The UK became the first country in the world to start getting the new Oxford-AstraZeneta vaccine

    • Last Update: 2021-01-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Jan. 5, 2021 // -- On Monday, the UK became the first country in the world to start using the COVID-19 vaccine developed jointly by Oxford University and AstraZenece, and plans to step up vaccination programmes across the country as rising infection rates put unprecedented pressure on the UK.
    Brian Pinker, an 82-year-old dialysis patient who was given the first shot at Oxford University Hospital at 7.30am that day, said: 'Doctors, nurses and other staff are doing a great job today and I would love to celebrate our 48th wedding anniversary with my wife later this year.
    the launch of the new vaccine comes at a critical time for british authorities, who are struggling with a surge in infections caused by a new variant of the virus that is more contagious.
    blockade will remain in place until the end of January as local officials in the UK come under increasing pressure.
    , britain's prime minister, said tougher measures were needed.
    Image source: Medicalxpress.com The UK is currently in the midst of an acute outbreak of COVID-19, with more than 50,000 new cases a day in the past six days, an increase of 54,990 on Sunday alone and With 454 deaths linked to viral infections, the total number of pandemic deaths now exceeds 75,000, and the UK is currently one of the worst affected countries in Europe, with some areas in north-east London infected at more than 1,000 per 100,000 people.
    Scotland leader Nicola Sturgeon said that from Tuesday, Scottish residents would be asked to stay at home (unless necessary) to help relieve pressure on hospitals and intensive care units, while under Scotland's latest lockdown, people could go out to exercise but only meet one of the family members of another family, and school closures would be extended until February, with the exception of children of key workers and children in social care.
    UK regulators last week authorized emergency use of a vaccine made by Oxford-AstraZeneta to provide public health officials with a second vaccine in the library; the UK's mass vaccination programme began on December 8th and was jointly developed by New York-based Pfizer and its German partner BioNTech.
    the UK has now acquired access to 100m doses of the Oxford-AstraZenecom vaccine, which is cheaper and easier to use than other vaccines, especially without the ultra-low temperature storage needed for a Pfizer vaccine.
    -AstraZenecom vaccine will be given to a handful of hospitals in the first few days to allow the health service to observe any adverse reactions from vaccinators, but the NHS says hundreds of new vaccination points will open later this week.
    Johnson said there was a big increase in vaccination programmes, but in some ways there was some controversy; both vaccines required two injections, and Pfizer had recommended a second shot within 21 days of the first shot, but the UK vaccine The Joint Committee on Vaccination and Immunization said the UK authorities should give as many people as possible the first dose of the vaccine, rather than set aside a shot to ensure that the first dose of the second, which may extend the time for two vaccinations from 21 days to 12 weeks.
    While vaccination requires two injections to fully prevent COVID-19 infection, it may provide a higher level of protection for inoculators after the first shot, making the first shot a priority or allowing the population to get the most out of vaccination in the short term.
    policymakers are now forced to balance the potential risks and benefits of such a change in the deadly COVID-19 pandemic.
    In the current situation of COVID-19 spreading in the UK, new virus variants are spreading rapidly, and as everyone knows in 2020, delays do cost people their lives, and when vaccination doses and population resources are limited, it may be better to vaccinate more people who may be less effective than to vaccinate only half of them.
    in England alone, 23,557 people were hospitalized for COVID-19 on Saturday, although figures for Northern Ireland, Scotland and Wales have not been updated recently, but this is higher than the UK-wide peak at the time of the first outbreak.
    the government is closing non-essential stores in London and parts of south-east Scotland ahead of Christmas in an attempt to curb the spread of new strains of the virus, health officials say the UK needs to take tougher action.
    Professor Andrew Pollard, a researcher who led the development of the Oxford-AstraZeneta vaccine, who was given the vaccine on Monday, said: 'It is a very proud moment for me to be able to get this new crown vaccine, and researchers at Oxford University and AstraZeneta will continue their efforts to make the vaccine available to the UK and around the world.'
    original source: UK first in world to start using Oxford-AstraZeneca VaccineThe U.K. on Monday became the first nation in the world to start using the COVID-19 vaccine developed by Oxford University and drugmaker AstraZeneca, ramping up up a nationwide inoculation program as rising applications are on the hold an run on British hospitals. Brian Pinker, an 82-year-old dialysis patient, received the first shot at 7:30 a.m. at Oxford University Hospital. "The nurses, doctors and staff today have all been brilliant, and I can now really look forward to celebrating my 48th wedding anniversary with my wife, Shirley, later this year," Pinker said in a statement released by the National Health Service.......
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.